Near East University is launching a research project that will draw attention to the risk factors related to SARS-CoV-2 seropositivity and plasma donation

Also available in: Türkçe

Added On: 25 September 2020, Friday, 08:04
Last Edited On: 25 September 2020, Friday, 08:04

Near East University is launching a research project that will draw attention to the risk factors related to SARS-CoV-2 seropositivity and plasma donation

In the study, which will be carried out in cooperation with the Near East University Faculty of Medicine Department of Medical Microbiology and Clinical Microbiology, Department of Infectious Diseases and Clinical Microbiology, Department of Internal Diseases and DESAM Institute, the importance of plasma donation will be emphasized as well as determining SARS-CoV-2 seropositivity and related risk factors.

With the research project titled “Determination of SARS-CoV-2 Seropositivity and Related Risk Factors in Persons Applying for COVID-19 Antibody Test”, SARS-CoV-2 antibodies in blood samples of people who applied to Near East University Hospital for COVID-19 antibody test will be carried out through ELISA test and SARS-CoV-2 seropositivity in the community will be investigated. People who agree to participate in the study will be asked to fill in a questionnaire after a blood sample is given. The responses of the participants in the questionnaire will be evaluated together with the ELISA test results and risk factors that may be associated with SARS-CoV-2 seropositivity will be determined.

Volunteers can donate plasma…
According to the information given by the Press and Public Relations Directorate of Near East University, the participants who have a high IgG level in their serum and whose COVID-19 PCR result have been confirmed as negative will be informed about plasma donation and the volunteers will be invited to the Near East University Hospital to donate plasma.

A Research Team of 8 experts rounded up…
In the research to be carried out under the responsibility of Assoc Prof. Dr. Umut Gazi, a member of Near East University Faculty of Medicine Department of Medical Microbiology and Clinical Microbiology, Near East University DESAM Institute Director Prof. Dr. Tamer Şanlıdağ, Head of the Department of Medical Microbiology and Clinical Microbiology Prof. Dr. Nedim Çakır, faculty member of Infectious Diseases and Clinical Microbiology Department Prof. Dr. Kaya Süer, faculty member of Internal Diseases Department Prof. Dr. Turgay Ulaş, faculty member of the Department of Medical Microbiology and Clinical Microbiology Assoc. Prof. Dr. Emrah Ruh and Ph.D. students M.Sc. Ayşegül Bostancı and M.Sc. Ulaş Hürdoğanoğlu will take place.

Near East University is launching a research project that will draw attention to the risk factors related to SARS-CoV-2 seropositivity and plasma donation

Prof. Dr. Tamer Şanlıdağ: “We are starting Plasma Treatment at Near East University Hospital…”
Near East University Vice-Rector, DESAM Institute Director and Microbiology Specialist Prof. Dr. Tamer Şanlıdağ stated that the necessary infrastructure preparations for Convalescence Plasma Treatment, which was previously announced to be carried out in cooperation with the Ministry of Health, have been completed, but the project could not be started, and that they will implement the project as a university with the start of antibody tests at the Near East University Hospital. Stating that in their previous studies, it has been determined that plasma treatment is one of the alternatives to be preferred in the treatment of COVID-19 disease and that the research results are also shared with the scientific world. Prof. Dr. Tamer Şanlıdağ also pointed out that Near East University Hospital is ready to apply plasma treatment, one of the treatment methods applied in the world.